Expertise in
4
conditions

Roman Hovorka

Cambridge, ENG, GB 
Expertise in
4
conditions
Cambridge, ENG, GB 

Overview

Roman Hovorka practices practicing medicine in Cambridge, United Kingdom.

Mr. Hovorka is highly rated in 4 conditions, according to our data. His clinical expertise encompasses Type 1 Diabetes (T1D), Low Blood Sugar, Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, and Hepato-Pancreato-Biliary Surgery.

He is actively involved in clinical research, co-authoring 255 peer reviewed articles and participating in 3 clinical trials.

Gender

Male

Locations

Cambridge, ENG, United Kingdom
Other Locations
Edinburgh, SCT, United Kingdom
Swansea, WLS, United Kingdom
Leeds, ENG, United Kingdom

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Open-label, Multi-centre, Multi-national, Randomized 2-period Crossover Study Comparing Closed-loop Insulin Delivery With Sensor-augmented Pump Therapy Over 4 Months in Children 1-7 Years With Type 1 Diabetes at Home, With an Extension.
Open-label, Multi-centre, Multi-national, Randomized 2-period Crossover Study Comparing Closed-loop Insulin Delivery With Sensor-augmented Pump Therapy Over 4 Months in Children 1-7 Years With Type 1 Diabetes at Home, With an Extension.
Enrollment Status: Completed
Publish Date: March 27, 2025
Intervention Type: Other, Device
Study Phase: Not Applicable
A Randomised Crossover Study Comparing Hybrid Closed-loop Insulin Delivery Using Ultra-rapid Acting Insulin to Hybrid Closed-loop Insulin Delivery Using Standard Rapid-acting Insulin in Children With Type 1 Diabetes in the Home Setting (FAST-Kids)
A Randomised Crossover Study Comparing Hybrid Closed-loop Insulin Delivery Using Ultra-rapid Acting Insulin to Hybrid Closed-loop Insulin Delivery Using Standard Rapid-acting Insulin in Children With Type 1 Diabetes in the Home Setting (FAST-Kids)
Enrollment Status: Completed
Publish Date: March 14, 2023
Intervention Type: Device
Study Phase: Not Applicable
A Randomised Study to Assess the Efficacy and Safety of Automated Closed-loop Glucose Control in Insulin Treated Type 2 Diabetes (Phase 1), Inpatient Hyperglycaemia Requiring Subcutaneous Insulin Therapy (Phase 2 and Phase 3) and to Evaluate Use of Closed-loop Applying Faster Insulin Aspart Versus Standard Insulin Aspart (Phase 4)
A Randomised Study to Assess the Efficacy and Safety of Automated Closed-loop Glucose Control in Insulin Treated Type 2 Diabetes (Phase 1), Inpatient Hyperglycaemia Requiring Subcutaneous Insulin Therapy (Phase 2 and Phase 3) and to Evaluate Use of Closed-loop Applying Faster Insulin Aspart Versus Standard Insulin Aspart (Phase 4)
Enrollment Status: Completed
Publish Date: October 19, 2018
Intervention Type: Device
Study Phase: Not Applicable
View 2 Less Clinical Trials

255 Total Publications

Assessing the efficacy, safety and utility of fully closed-loop insulin delivery compared to standard insulin therapy with a continuous glucose monitor in adults with type 2 diabetes (COYOTE study): a randomised parallel study protocol.
Assessing the efficacy, safety and utility of fully closed-loop insulin delivery compared to standard insulin therapy with a continuous glucose monitor in adults with type 2 diabetes (COYOTE study): a randomised parallel study protocol.
Journal: BMJ open
Published: May 19, 2026

Frequently Asked Questions about Roman Hovorka

Is Roman Hovorka a top-rated expert for Type 1 Diabetes (T1D)?

MediFind is an objective health platform that identifies experts based on real-world data. Roman Hovorka is classified as an Elite expert for Type 1 Diabetes (T1D), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Roman Hovorka participate in research or clinical trials?

Yes. Roman Hovorka has published 255 articles and abstracts on conditions like Type 1 Diabetes (T1D). You can view a list of Roman Hovorka's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Hovorka's expertise for a condition
ConditionClose
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile